
The project intends to use graphene-based bio-medical sensors in integration with existing diagnostic tools or other portable electronic devices such as smartphones to enable real-time and portable disease detection.
Sparc Technologies Ltd (ASX:SPN) has established a new graphene bio-medical division aimed at developing non-invasive graphene-based breath sensing devices for detection of diseases in humans and animals.
Sparc will advance the project together with cornerstone shareholder, strategic partner and leading graphene research centre the University of Adelaide (UA) in order to seek to establish and develop non-invasive sensing devices for human and veterinarian applications.
The focus of the project will be research into graphene-based sensing devices for the detection of a selection of volatile organic compounds (VOCs) present in exhaled breath that are understood to be indicators of disease.
Continue reading… “Sparc sets up graphene sensor project to detect human and animal diseases”










